|
Treatment type (SR vs. RFA)
|
1.35 (0.86–2.11)
|
0.193
| | |
|
Male
|
0.97 (0.60–1.56)
|
0.903
| | |
|
Age (≥ 60y vs, < 60y)
|
0.49 (0.31–0.76)
|
0.002
|
0.47 (0.30–0.73)
|
0.001
|
|
BMI (≥ 24 kg/m2 vs. < 24 kg/m2)
|
1.29 (0.83–2.02)
|
0.256
| | |
|
Alcohol use
|
1.04 (0.63–1.72)
|
0.871
| | |
|
HBV
|
1.29 (0.83–2.03)
|
0.256
| | |
|
HCV
|
0.73 (0.47–1.14)
|
0.164
| | |
|
Child‐Pugh class A
|
1.14 (0.42–3.13)
|
0.795
| | |
|
Cirrhosis
|
0.59 (0.37–0.96)
|
0.032
|
0.56 (0.35–0.90)
|
0.018
|
|
Ascites
|
0.76 (0.35–1.65)
|
0.482
| | |
|
Total bilirubin (≥ 1.3 mg/dL vs. < 1.3 mg/dL)
|
0.87 (0.52–1.47)
|
0.609
| | |
|
Albumin (≥ 3.5 g/dL vs. < 3.5 g/dL)
|
1.08 (0.50–2.36)
|
0.840
| | |
|
ALBI grade 1 vs. 2/3
|
0.82 (0.39–1.70)
|
0.589
| | |
|
AFP (≥ 200 ng/ml vs. < 200 ng/ml)
|
0.78 (0.44–1.40)
|
0.406
| | |
|
Tumor size (≥ 1.8 cm vs. < 1.8 cm)
|
1.19 (0.75–1.87)
|
0.467
| | |
